Interleukin-6 protects anterior horn neurons from lethal virus-induced injury

Journal of Neuroscience

Volumn 23, Issue 2, 2003, Pages 481-492

  Pavelko, Kevin D ^a   Howe, Charles L ^a   Drescher, Kristen M ^b   Gamez, Jeff D ^a   Johnson, Aaron J ^a   Wei, Tao ^c   Ransohoff, Richard M ^c   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemokine; CNS; Interleukin 6; Multiple sclerosis; Neuron; Theiler's murine encephalomyelitis virus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HORN CELL; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; CELL POPULATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HAPLOTYPE; HUMORAL IMMUNITY; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE CELL LESION; NEUROBLASTOMA; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL CORD; VIRUS INFECTION; VIRUS TITRATION;

EID: 0037439877     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-02-00481.2003     Document Type: Article

References (52)

1. Akira S (1997) IL-6-regulated transcription factors. Int J Biochem Cell Biol 29:1401-1418.
2. Asensio VC, Campbell IL (2001) Chemokines and viral diseases of the central nervous system. Adv Virus Res 56:127-173.
3. Borson ND, Paul C, Lin X, Nevala WK, Strausbauch MA, Rodriguez M, Wettstein PJ (1997) Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol 71:5244-5250.
4. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC (1999) Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 163:3963-3968.
5. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194:209-221.
6. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, Kluger MJ (1995) Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 268:R78-R84.
7. Dalrymple SA, Lucian LA, Slattery R, McNeil T, Aud DM, Fuchino S, Lee F, Murray R (1995) Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immunol 63:2262-2268.
8. Dethlefs S, Escriou N, Brahic M, van der Werf S, Larsson-Sciard EL (1997) Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol 71:5361-5365.
9. Drescher KM, Rivera-Quinones C, Lucchinetti CF, Rodriguez M (1998) Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis. J Neuroimmunol 88:111-119.
10. Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M (1999) CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. Brain Pathol 9:21-31.
11. Eggett CJ, Crosier S, Manning P, Cookson MR, Menzies FM, McNeil CJ, Shaw PJ (2000) Development and characterization of a glutamate-sensitive motor neuron cell line. J Neurochem 74:1895-1902.
12. Hama T, Miyamoto M, Tsukui H, Nishio C, Hatanaka H (1989) Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett 104:340-344.
13. Ikeda K, Kinoshita M, Tagaya N, Shiojima T, Taga T, Yasukawa K, Suzuki H, Okano A (1996) Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res 726:91-97.
14. Johnson AJ, Upshaw J, Pavelko KD, Rodriguez M, Pease LR (2001) Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J 15:2760-2762.
15. Kanda T, McManus JE, Nagai R, Imai S, Suzuki T, Yang D, McManus BM, Kobayashi I (1996) Modification of viral myocarditis in mice by interleukin-6. Circ Res 78:848-856.
16. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
17. Kopf M, Herren S, Wiles MV, Pepys MB, Kosco-Vilbois MH (1998) Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J Exp Med 188:1895-1906.
18. Lin X, Thiemann NR, Pease LR, Rodriguez M (1995) VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214:91-99.
19. Lindsley MD, Rodriguez M (1989) Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol 142:2677-2682.
20. Lipton HL (1975) Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immunol 11:1147-1155.
21. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE (2000) The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165:2327-2330.
22. Maeda Y, Matsumoto M, Hori O, Kuwabara K, Ogawa S, Yan SD, Ohtsuki T, Kinoshita T, Kamada T, Stern DM (1994) Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med 180:2297-2308.
23. Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, Hay RT, Davies AM (2000) Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol 148:325-332.
24. Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, Rodriguez M (2000) Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis. J Neurovirol 6[Suppl 1]:44-S52.
25. Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M (1996) Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol 70:1729-1737.
26. Njenga MK, Asakura K, Hunter SF, Wettstein P, Pease LR, Rodriguez M (1997) The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol 71:8592-8601.
27. Penkowa M, Moos T, Carrasco J, Hadberg H, Molinero A, Bluethmann H, Hidalgo J (1999) Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25:343-357.
28. Pierce ML, Rodriguez M (1989) Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J Histotechnol 12:35-36.
29. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561-563.
30. Ransohoff RM, Wei T, Pavelko KD, Lee J-C, Murray PD, Rodriguez M (2001) Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T-cells and viral persistence. J Virol 76:2217-2224.
31. Rodriguez M, David CS (1985) Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol 135:2145-2148.
32. Rodriguez M, Leibowitz JL, Lampert PW (1983) Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 13:426-433.
33. Rodriguez M, Lafuse WP, Leibowitz J, David CS (1986a) Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology 36:964-970.
34. Rodriguez M, Leibowitz J, David CS (1986b) Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med 163:620-631.
35. Rodriguez M, Lindsley MD, Pierce ML (1991a) Role of T cells in resistance to Theiler's virus infection. Microb Pathog 11:269-281.
36. Rodriguez M, Nickerson C, Patick AK, David CS (1991b) Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination. J Immunol 146:2596-2602.
37. Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R (1993) Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J Immunol 151:266-276.
38. Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL (1994) Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J Immunol 153:3811-3821.
39. Rodriguez M, Roos RP, McGavern D, Zoecklein L, Pavelko K, Sang H, Lin X (2000) The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. Virology 275:9-19.
40. Roldan E, Brieva JA (1991) Terminal differentiation of human bone marrow cells capable of spontaneous and high-rate immunoglobulin secretion: role of bone marrow stromal cells and interleukin 6. Eur J Immunol 21:2671-2677.
41. Roldan E, Rodriguez C, Navas G, Parra C, Brieva JA (1992) Cytokine network regulating terminal maturation of human bone marrow B cells capable of spontaneous and high rate Ig secretion in vitro. J Immunol 149:2367-2371.
42. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6:315-325.
43. Rubio N, De Felipe C, Torres C (1990) Theiler's murine encephalomyelitis virus-binding activity on neural and non-neural cell lines and tissues. J Gen Virol 71:2867-2872.
44. Sarawar SR, Brooks JW, Cardin RD, Mehrpooya M, Doherty PC (1998) Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice. Virology 249:359-366.
45. Schafer KH, Mestres P, Marz P, Rose-John S (1999) The IL-6/sIL-6R fusion protein hyper-IL-6 promotes neurite outgrowth and neuron survival in cultured enteric neurons. J Interferon Cytokine Res 19:527-532.
46. Sidman RL, Angevine JB, Pierce ET (1971) Atlas of the mouse brain and spinal cord. Cambridge, MA: Harvard UP.
47. Strelau J, Sullivan A, Bottner M, Lingor P, Falkenstein E, Suter-Crazzolara C, Galter D, Jaszai J, Krieglstein K, Unsicker K (2000) Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci 20:8597-8603.
48. Strestik BD, Olbrich AR, Hasenkrug KJ, Dittmer U (2001) The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukemia virus). J Gen Virol 82:1349-1354.
49. Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S (1995) Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493.
50. Tosato G, Seamon KB, Goldman ND, Sehgal PB, May LT, Washington GC, Jones KD, Pike SE (1988) Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). Science 239:502-504.
51. Wang J, Homer RJ, Chen Q, Elias JA (2000) Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J Immunol 165:4051-4061.
52. Zhong J, Dietzel ID, Wahle P, Kopf M, Heumann R (1999) Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J Neurosci 19:4305-4313.